Argentina Approves Record 291 Clinical Trials in 2026, Targets Health Investment

Argentina approved 291 pharmaceutical trials in the first nine months of 2026, exceeding the full-year 2025 total, signaling a surge in clinical research activity. The government aims to leverage this momentum to attract health-sector investment, though specific policy measures remain unspecified. This marks a notable acceleration in the country's clinical research pipeline, potentially enhancing its position in global drug development.